Please Wait.....
Report
Europe Drug Delivery Devices Market
Market Report I 2024-08-01 I 299 Pages I Data Bridge Market Research
The Europe drug delivery devices market is expected to reach USD 864.31 billion by 2031 from USD 497.13 billion in 2023, growing at a CAGR of 7.5% in the forecast period of 2024 to 2031.
Market Segmentation:
Europe Drug Delivery Devices Market, By Product Type (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ophthalmic Drug Delivery, Nasal Drug Delivery, Pulmonary Drug Delivery, Transmucosal Drug Delivery, and Implantable Drug Delivery), End User (Hospitals, Home Healthcare, Clinics, Community Healthcare, and Others), Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, and Online Pharmacy), Country (Germany, U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, and rest of Europe) - Industry Trends and Forecast to 2031
Overview of Europe Drug Delivery Devices Market Dynamics:
Driver
- Rising prevalence of chronic disease and non-chronic disease
Restraint
- High costs of injectable drugs
Opportunity
- Rising acceptance of self-administering drug devices
Market Players:
The key market players operating in the Europe drug delivery devices market are listed below:
- Johnson & Johnson Services, Inc.
- Novartis AG
- F.Hoffmann-La Roche Ltd
- Bayer AG
- Pfizer Inc.
- 3M
- AbbVie Inc.
- Amgen Inc.
- BD
- Elcam Medical
- Gerresheimer AG
- GSK plc.
- Insulet Corporation
- Medmix
- Merck & Co., Inc.
- OraSure Technologies Inc.
- Sanofi
- SMC Ltd.
- ViVO Smart Medical Devices Ltd.
- West Pharmaceutical Services Inc.
1 INTRODUCTION 65
1.1 OBJECTIVES OF THE STUDY 65
1.2 MARKET DEFINITION 65
1.3 OVERVIEW OF THE EUROPE DRUG DELIVERY DEVICES MARKET 65
1.4 CURRENCY AND PRICING 67
1.5 LIMITATIONS 67
1.6 MARKETS COVERED 67
2 MARKET SEGMENTATION 71
2.1 MARKETS COVERED 71
2.2 GEOGRAPHICAL SCOPE 72
2.3 YEARS CONSIDERED FOR THE STUDY 73
2.4 DBMR TRIPOD DATA VALIDATION MODEL 74
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 77
2.6 MULTIVARIATE MODELLING 78
2.7 MARKET END USER COVERAGE GRID 79
2.8 PRODUCT TYPE LIFELINE CURVE 79
2.9 DBMR MARKET POSITION GRID 80
2.10 VENDOR SHARE ANALYSIS 81
2.11 SECONDARY SOURCES 82
2.12 ASSUMPTIONS 82
3 EXECUTIVE SUMMARY 83
4 PREMIUM INSIGHTS 88
4.1 PORTERS FIVE FORCES 89
4.2 PESTEL ANALYSIS 90
5 REGULATORY FRAMEWORK 91
6 MARKET OVERVIEW 92
6.1 DRIVERS 94
6.1.1 RISING PREVALENCE OF CHRONIC DISEASE AND NON-CHRONIC DISEASE 94
6.1.2 GROWTH IN THE DEVELOPMENT OF BIOLOGICS DRUGS DEVICES 94
6.1.3 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT 96
6.1.4 INCREASED FOCUS ON PERSONALIZED MEDICINE AND DEVICES 96
6.2 RESTRAINTS 97
6.2.1 RISK OF NEEDLE-STICK INJURIES AND SIDE EFFECTS 97
6.2.2 HIGH COSTS OF INJECTABLE DRUGS 98
6.2.3 STRINGENT REGULATORY SCENARIO 99
6.3 OPPORTUNITIES 100
6.3.1 RISING ACCEPTANCE OF SELF-ADMINISTERING DRUG DEVICES 100
6.3.2 RISING DEMAND FOR BIOSIMILAR AND GENERIC DRUGS 100
6.3.3 THERAPEUTIC ADVANCEMENTS IN THE FIELD OF DRUG DELIVERY 101
6.4 CHALLENGES 101
6.4.1 SIDE EFFECTS OF DRUG DELIVERY SYSTEMS 101
6.4.2 INCREASE IN THE NUMBER OF ALTERNATIVES OF DRUG DELIVERY 102
7 EUROPE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE 103
7.1 OVERVIEW 104
7.2 ORAL DRUG DELIVERY 107
7.2.1 SOLID ORAL DRUGS 108
7.2.1.1 TABLETS 108
7.2.1.2 CAPSULES 108
7.2.1.3 PILLS 108
7.2.1.4 POWDERS 108
7.2.2 LIQUID ORAL DRUGS 109
7.2.2.1 SYRUPS 109
7.2.2.2 SOLUTIONS 109
7.2.3 SEMI SOLID ORAL DRUGS 109
7.2.3.1 GELS 109
7.2.3.2 EMULSIONS 109
7.2.3.3 ELIXIRS 110
7.3 INJECTABLE DRUG DELIVERY 110
7.3.1 INJECTABLE DRUG DELIVERY FORMULATIONS 111
7.3.1.1 CONVENTIONAL DRUG DELIVERY FORMULATIONS 111
7.3.1.2 NOVEL DRUG DELIVERY FORMULATIONS 111
7.3.1.3 LONG ACTING INJECTION FORMULATIONS 111
7.3.2 INJECTABLE DRUG DELIVERY DEVICES 112
7.3.2.1 CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES 112
7.3.2.1.1 BY MATERIAL 112
7.3.2.1.1.1 GLASS 112
7.3.2.1.1.2 PLASTIC 113
7.3.2.1.2 BY PRODUCT TYPE 113
7.3.2.1.2.1 FILLABLE 113
7.3.2.1.2.2 PRE-FILLED 113
7.3.2.1.3 BY USABILITY 113
7.3.2.1.3.1 REUSABLE SYRINGES 113
7.3.2.1.3.2 DISPOSABLE SYRINGES 114
7.3.2.2 SELF INJECTION DRUG DELIVERY DEVICES 114
7.3.2.2.1 NEEDLE FREE INJECTORS 114
7.3.2.2.2 WEARABLE INJECTORS 114
7.3.2.2.3 PEN INJECTOR 114
7.3.2.2.4 AUTO INJECTORS 114
7.3.2.2.5 OTHERS 115
7.4 TOPICAL DRUG DELIVERY 116
7.4.1 TRANSDERMAL DRUG DELIVERY FORMULATIONS 116
7.4.1.1 SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS 117
7.4.1.1.1 OINTMENTS 117
7.4.1.1.2 CREAMS 117
7.4.1.1.3 LOTIONS 117
7.4.1.1.4 GELS 117
7.4.1.1.5 PASTES 117
7.4.1.2 LIQUID TOPICAL DRUG DELIVERY FORMULATIONS 118
7.4.1.2.1 SUSPENSIONS 118
7.4.1.2.2 SOLUTIONS 118
7.4.1.3 SOLID TOPICAL DRUG DELIVERY FORMULATIONS 118
7.4.1.3.1 POWDER 118
7.4.1.3.2 SUPPOSITORS 119
7.5 OPHTHALMIC DRUG DELIVERY 119
7.5.1 OCCULAR DRUG DELIVERY FORMULATIONS 120
7.5.1.1 LIQUID OCCULAR DRUG DELIVERY FORMULATIONS 120
7.5.1.1.1 SOLUTIONS 120
7.5.1.1.2 SUSPENSIONS 120
7.5.1.2 SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS 121
7.5.1.2.1 GELS 121
7.5.1.2.2 OINTMENTS 121
7.5.2 OCCULAR DRUG DELIVERY DEVICES 121
7.6 NASAL DRUG DELIVERY 121
7.6.1 NASAL DROPS 122
7.6.2 NASAL SPRAYS 122
7.6.3 NASAL POWDERS 122
7.6.4 NASAL GELS 122
7.7 PULMONARY DRUG DELIVERY 122
7.7.1 METERED DOSE INHALERS (MDI) 123
7.7.2 DRY POWDER INHALERS (DPI) 123
7.7.3 NEBULIZERS 123
7.7.3.1 JET NEBULIZERS 123
7.7.3.2 ULTRASONIC NEBULIZERS 124
7.7.3.3 SOFT MIST NEBULIZERS 124
7.8 TRANSMUCOSAL DRUG DELIVERY 124
7.8.1 ORAL TRANSMUCOSAL DRUG DELIVERY 125
7.8.1.1 BUCCAL DRUG DELIVERY 125
7.8.1.2 SUBLINGUAL DRUG DELIVERY 125
7.8.2 OTHER TRANSMUCOSAL DRUG DELIVERY 125
7.8.2.1 RECTAL TRANSMUCOSAL DRUG DELIVERY 125
7.8.2.2 VAGINAL TRANSMUCOSAL DRUG DELIVERY 126
7.9 IMPLANTABLE DRUG DELIVERY 126
7.9.1 PASSIVE IMPLANTABLE DRUG DELIVERY DEVICES 126
7.9.2 ACTIVE IMPLANTABLE DRUG DELIVERY DEVICES 126
8 EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER 127
8.1 OVERVIEW 128
8.2 HOSPITALS 131
8.3 HOME HEALTHCARE 131
8.4 CLINICS 132
8.5 COMMUNITY HEALTHCARE 132
8.6 OTHERS 133
9 EUROPE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL 134
9.1 OVERVIEW 135
9.2 DIRECT TENDERS 138
9.3 HOSPITAL PHARMACIES 138
9.4 PHARMACY STORES 139
9.5 ONLINE PHARMACY 139
10 EUROPE DRUG DELIVERY DEVICES MARKET, BY REGION 140
10.1 EUROPE 142
10.1.1 GERMANY 151
10.1.2 FRANCE 159
10.1.3 ITALY 167
10.1.4 U.K. 175
10.1.5 SWITZERLAND 183
10.1.6 SPAIN 191
10.1.7 NETHERLANDS 199
10.1.8 RUSSIA 207
10.1.9 TURKEY 215
10.1.10 BELGIUM 223
10.1.11 REST OF EUROPE 231
11 EUROPE DRUG DELIVERY DEVICES MARKET: COMPANY LANDSCAPE 232
11.1 COMPANY SHARE ANALYSIS: EUROPE 232
12 SWOT ANALYSIS 233
13 COMPANY PROFILE 234
13.1 JOHNSON & JOHNSON SERVICES, INC. 234
13.1.1 COMPANY SNAPSHOT 234
13.1.2 REVENUE ANALYSIS 234
13.1.3 COMPANY SHARE ANALYSIS 235
13.1.4 PRODUCT PORTFOLIO 235
13.1.5 RECENT DEVELOPMENTS 237
13.2 NOVARTIS AG 239
13.2.1 COMPANY SNAPSHOT 239
13.2.2 REVENUE ANALYSIS 239
13.2.3 COMPANY SHARE ANALYSIS 240
13.2.4 PRODUCT PORTFOLIO 240
13.2.5 RECENT DEVELOPMENTS 240
13.3 F. HOFFMANN-LA ROCHE LTD 242
13.3.1 COMPANY SNAPSHOT 242
13.3.2 REVENUE ANALYSIS 242
13.3.3 COMPANY SHARE ANALYSIS 243
13.3.4 PRODUCT PORTFOLIO 243
13.3.5 RECENT DEVELOPMENT 243
13.4 BAYER AG 244
13.4.1 COMPANY SNAPSHOT 244
13.4.2 REVENUE ANALYSIS 244
13.4.3 COMPANY SHARE ANALYSIS 245
13.4.4 PRODUCT PORTFOLIO 245
13.5 PFIZER INC. 246
13.5.1 COMPANY SNAPSHOT 246
13.5.2 REVENUE ANALYSIS 246
13.5.3 COMPANY SHARE ANALYSIS 247
13.5.4 PRODUCT PORTFOLIO 247
13.5.5 RECENT DEVELOPMENT 247
13.6 3M 248
13.6.1 COMPANY SNAPSHOT 248
13.6.2 REVENUE ANALYSIS 248
13.6.3 PRODUCT PORTFOLIO 249
13.6.4 RECENT DEVELOPMENTS 249
13.7 ABBVIE INC. 250
13.7.1 COMPANY SNAPSHOT 250
13.7.2 REVENUE ANALYSIS 251
13.7.3 PRODUCT PORTFOLIO 251
13.7.4 RECENT DEVELOPMENTS 252
13.8 AMGEN INC. 253
13.8.1 COMPANY SNAPSHOT 253
13.8.2 REVENUE ANALYSIS 253
13.8.3 PRODUCT PORTFOLIO 254
13.8.4 RECENT DEVELOPMENTS 255
13.9 BD 256
13.9.1 COMPANY SNAPSHOT 256
13.9.2 REVENUE ANALYSIS 256
13.9.3 PRODUCT PORTFOLIO 257
13.9.4 RECENT DEVELOPMENT 260
13.10 ELCAM MEDICAL 261
13.10.1 COMPANY SNAPSHOT 261
13.10.2 PRODUCT PORTFOLIO 261
13.10.3 RECENT DEVELOPMENT 262
13.11 ENABLE INJECTIONS 263
13.11.1 COMPANY SNAPSHOT 263
13.11.2 PRODUCT PORTFOLIO 263
13.11.3 RECENT DEVELOPMENTS 264
13.12 GERRESHEIMER AG 266
13.12.1 COMPANY SNAPSHOT 266
13.12.2 REVENUE ANALYSIS 266
13.12.3 PRODUCT PORTFOLIO 267
13.12.4 RECENT DEVELOPMENTS 270
13.13 GSK PLC. 272
13.13.1 COMPANY SNAPSHOT 272
13.13.2 REVENUE ANALYSIS 272
13.13.3 PRODUCT PORTFOLIO 273
13.13.4 RECENT DEVELOPMENTS 275
13.14 INSULET CORPORATION 277
13.14.1 COMPANY SNAPSHOT 277
13.14.2 REVENUE ANALYSIS 277
13.14.3 PRODUCT PORTFOLIO 278
13.14.4 RECENT DEVELOPMENTS 278
13.15 MEDMIX 279
13.15.1 COMPANY SNAPSHOT 279
13.15.2 REVENUE ANALYSIS 279
13.15.3 PRODUCT PORTFOLIO 280
13.15.4 RECENT DEVELOPMENTS 281
13.16 MERCK & CO., INC. 283
13.16.1 COMPANY SNAPSHOT 283
13.16.2 REVENUE ANALYSIS 283
13.16.3 PRODUCT PORTFOLIO 284
13.16.4 RECENT DEVELOPMENT 284
13.17 ORASURE TECHNOLOGIES INC. 285
13.17.1 COMPANY SNAPSHOT 285
13.17.2 REVENUE ANALYSIS 285
13.17.3 PRODUCT PORTFOLIO 286
13.17.4 RECENT DEVELOPMENT 286
13.18 SANOFI 287
13.18.1 COMPANY SNAPSHOT 287
13.18.2 REVENUE ANALYSIS 287
13.18.3 PRODUCT PORTFOLIO 288
13.18.4 RECENT DEVELOPMENTS 290
13.19 SMC LTD. 291
13.19.1 COMPANY SNAPSHOT 291
13.19.2 REVENUE ANALYSIS 291
13.19.3 PRODUCT PORTFOLIO 292
13.19.4 RECENT DEVELOPMENTS 292
13.20 VIVO SMART MEDICAL DEVICES LTD. 293
13.20.1 COMPANY SNAPSHOT 293
13.20.2 PRODUCT PORTFOLIO 293
13.20.3 RECENT DEVELOPMENT 293
13.21 WEST PHARMACEUTICAL SERVICES, INC. 294
13.21.1 COMPANY SNAPSHOT 294
13.21.2 REVENUE ANALYSIS 294
13.21.3 PRODUCT PORTFOLIO 295
13.21.4 RECENT DEVELOPMENT 295
14 QUESTIONNAIRE 296
15 RELATED REPORTS 299
13.20.3 RECENT DEVELOPMENT 293
13.21 WEST PHARMACEUTICAL SERVICES, INC. 294
13.21.1 COMPANY SNAPSHOT 294
13.21.2 REVENUE ANALYSIS 294
13.21.3 PRODUCT PORTFOLIO 295
13.21.4 RECENT DEVELOPMENT 295
14 QUESTIONNAIRE 296
15 RELATED REPORTS 299
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security